Literature DB >> 26091296

Expanded HIV testing coverage is associated with decreases in late HIV diagnoses.

Yusuf Ransome1, Arpi Terzian, Diane Addison, Sarah Braunstein, Julie Myers, Bisrat Abraham, Denis Nash.   

Abstract

OBJECTIVE: Expanded HIV testing coverage could result in earlier diagnosis of HIV, along with reduced morbidity, mortality and onward HIV transmission.
DESIGN: Longitudinal analysis of aggregate, population-based surveillance data within New York City (NYC) ZIP codes.
METHODS: We examined new HIV diagnoses and recent HIV testing to examine whether changes in recent HIV testing coverage (last 12 months) were associated with changes in late HIV diagnosis rates within NYC ZIP codes during 2003-2010, a period of expansion of HIV testing in NYC.
RESULTS: Overall, recent HIV testing coverage increased from 23 to 31% during 2003-2010, while the rate of late HIV diagnoses decreased from 14.9 per 100 000 to 10.6 per 100 000 population. Within ZIP codes, each 10% absolute increase in recent HIV testing coverage was associated with a 2.5 per 100 000 absolute decrease in the late HIV diagnosis rate. ZIP codes with the largest changes in HIV testing coverage among men were more likely to have the largest (top quartile) declines in late HIV diagnosis rates among men [adjusted odds ratio (aOR)men = 4.0; 95% confidence interval (95% CI) 1.5-10.8], compared with ZIP codes with no or small changes in HIV testing coverage. This association was not significant for women (aORwomen = 1.4; 95% CI 0.50-4.3). Significant geographic disparities in late HIV diagnosis rates persisted in 2009/2010.
CONCLUSION: Increases in recent HIV testing coverage may have reduced late HIV diagnoses among men. Persistent geographic disparities underscore the need for continued expansion of HIV testing to promote earlier HIV diagnosis.

Entities:  

Mesh:

Year:  2015        PMID: 26091296      PMCID: PMC4896217          DOI: 10.1097/QAD.0000000000000684

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  32 in total

1.  Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1999-12-10

2.  Assessing the impact of a community-wide HIV testing scale-up initiative in a major urban epidemic.

Authors:  Julie E Myers; Sarah L Braunstein; Colin W Shepard; Blayne H Cutler; Andrea R Mantsios; Monica M Sweeney; Benjamin W Tsoi
Journal:  J Acquir Immune Defic Syndr       Date:  2012-09-01       Impact factor: 3.731

3.  Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis.

Authors:  Gary Marks; Lytt I Gardner; Jason Craw; Nicole Crepaz
Journal:  AIDS       Date:  2010-11-13       Impact factor: 4.177

4.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

5.  Impact of late presentation on the risk of death among HIV-infected people in France (2003-2009).

Authors:  Claire Montlahuc; Marguerite Guiguet; Sophie Abgrall; Vincent Daneluzzi; Francine de Salvador; Odile Launay; Valérie Martinez; Marialuisa Partisani; Christian Pradier; Elisabeth Rouveix; Nadia Valin; Sophie Grabar; Dominique Costagliola
Journal:  J Acquir Immune Defic Syndr       Date:  2013-10-01       Impact factor: 3.731

6.  Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach.

Authors:  Kathleen McDavid Harrison; Tebitha Kajese; H Irene Hall; Ruiguang Song
Journal:  Public Health Rep       Date:  2008 Sep-Oct       Impact factor: 2.792

7.  Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008.

Authors:  Eileen Schneider; Suzanne Whitmore; Kathleen M Glynn; Kenneth Dominguez; Andrew Mitsch; Matthew T McKenna
Journal:  MMWR Recomm Rep       Date:  2008-12-05

8.  The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection.

Authors:  H B Krentz; M C Auld; M J Gill
Journal:  HIV Med       Date:  2004-03       Impact factor: 3.180

9.  U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.

Authors:  Keri N Althoff; Kate Buchacz; H Irene Hall; Jinbing Zhang; David B Hanna; Peter Rebeiro; Stephen J Gange; Richard D Moore; Mari M Kitahata; Kelly A Gebo; Jeffrey Martin; Amy C Justice; Michael A Horberg; Robert S Hogg; Timothy R Sterling; Angela Cescon; Marina B Klein; Jennifer E Thorne; Heidi M Crane; Michael J Mugavero; Sonia Napravnik; Gregory D Kirk; Lisa P Jacobson; John T Brooks
Journal:  Ann Intern Med       Date:  2012-09-04       Impact factor: 25.391

10.  Late HIV diagnosis is a major risk factor for intensive care unit admission in HIV-positive patients: a single centre observational cohort study.

Authors:  Julia Shrosbree; Lucy J Campbell; Fowzia Ibrahim; Phillip Hopkins; Marcela Vizcaychipi; Stephanie Strachan; Frank A Post
Journal:  BMC Infect Dis       Date:  2013-01-19       Impact factor: 3.090

View more
  9 in total

1.  "We Deserve Better!": Perceptions of HIV Testing Campaigns Among Black and Latino MSM in New York City.

Authors:  Kathryn Drumhiller; Ashley Murray; Zaneta Gaul; Tiffiany M Aholou; Madeline Y Sutton; Jose Nanin
Journal:  Arch Sex Behav       Date:  2017-04-25

Review 2.  The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions.

Authors:  David C Perlman; Ashly E Jordan
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

3.  Estimates of the Time From Seroconversion to Antiretroviral Therapy Initiation Among People Newly Diagnosed With Human Immunodeficiency Virus From 2006 to 2015, New York City.

Authors:  McKaylee M Robertson; Sarah L Braunstein; Donald R Hoover; Sheng Li; Denis Nash
Journal:  Clin Infect Dis       Date:  2020-11-05       Impact factor: 9.079

4.  Structural inequalities drive late HIV diagnosis: The role of black racial concentration, income inequality, socioeconomic deprivation, and HIV testing.

Authors:  Yusuf Ransome; Ichiro Kawachi; Sarah Braunstein; Denis Nash
Journal:  Health Place       Date:  2016-10-19       Impact factor: 4.078

5.  Foreign-born status as a predictor of engagement in HIV care in a large US metropolitan health system.

Authors:  Julie H Levison; Susan Regan; Iman Khan; Kenneth A Freedberg
Journal:  AIDS Care       Date:  2016-07-28

6.  What Triggers a Diagnosis of HIV Infection in the Tokyo Metropolitan Area? Implications for Preventing the Spread of HIV Infection in Japan.

Authors:  Takeshi Nishijima; Misao Takano; Shoko Matsumoto; Miki Koyama; Yuko Sugino; Miwa Ogane; Kazuko Ikeda; Yoshimi Kikuchi; Shinichi Oka; Hiroyuki Gatanaga
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

7.  Area-level HIV risk and socioeconomic factors associated with willingness to use PrEP among Black people in the U.S. South.

Authors:  Yusuf Ransome; Laura M Bogart; Ichiro Kawachi; Anna Kaplan; Kenneth H Mayer; Bisola Ojikutu
Journal:  Ann Epidemiol       Date:  2019-11-30       Impact factor: 3.797

8.  Different transmission routes and the risk of advanced HIV disease: A systematic review and network meta-analysis of observational studies.

Authors:  Qiaosen Chen; Ding Zeng; Yangyang She; Yuhan Lyu; Xiao Gong; Matthew J Feinstein; Yi Yang; Hongbo Jiang
Journal:  EClinicalMedicine       Date:  2019-11-02

9.  Low variation in initial CD4 cell count in a HIV referral center, in Salvador, Brazil, from 2002 to 2015.

Authors:  Marcela Fonseca Pereira; Estela Luz; Eduardo Martins Netto; Manoel Henrique Fonseca Barbosa; Carlos Brites
Journal:  Braz J Infect Dis       Date:  2018-06-06       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.